Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04466501 · ClinicalTrials.gov registry record · NA

ACR | LAB Urine Analysis Test System Evaluation of Performance

A NA study, sponsored by Healthy.io.

Completed
Registry status
NA
Development phase
375
Enrollment target

NCT04466501 is a NA study that has completed, run by Healthy.io. The registered enrollment target is 375 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04466501, a NA study, has completed, sponsored by Healthy.io.

COMPLETED
Registry status
NA
Development phase
375 participants
Enrollment target

Study Summary

The ACR LAB is a prescription-only, nurse- or clinician-conducted in vitro diagnostic (IVD) device. The test is for the qualitative and semi- quantitative detection of Albumin, Creatinine, and the Albumin-to- Creatinine Ratio. The device is composed of a kit and a smartphone application using an image recognition algorithm. The degree of agreement of the ACR \| LAB as compared to the comparator device will be tested. Urine samples will be tested by a separate professional user on each device.

Interventions

  • DEVICE ACR LAB

Trial Details

FieldValue
Enrollment Target 375 participants
Start Date 2019-06-30
Est. Completion 2019-09-30
Phase NA

Sponsor

Healthy.io

7 total trials

What the Registry Record Tells You About NCT04466501

The ClinicalTrials.gov registry entry for NCT04466501 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthy.io, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ACR LAB is the first listed.

NCT04466501 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04466501 about?

NCT04466501 is a clinical study titled "ACR | LAB Urine Analysis Test System Evaluation of Performance". The ACR LAB is a prescription-only, nurse- or clinician-conducted in vitro diagnostic (IVD) device. The test is for the qualitative and semi- quantitative detection of Albumin, Creatinine, and the Albumin-to- Creatinine Ratio. The device is composed of a kit and a smartphone application using an ima...

What is the current status of trial NCT04466501?

This trial is currently completed. It is a NA study. The enrollment target is 375 participants. The study started on 2019-06-30. Estimated completion is 2019-09-30.

What interventions are being tested in trial NCT04466501?

The interventions under investigation include: ACR LAB (DEVICE).

Who is sponsoring clinical trial NCT04466501?

This trial is sponsored by Healthy.io, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.